FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Kit, Rna Detection, Human Papillomavirus
PMA: P120007
·
Supplement: S024
·
Decision Sep 16, 2019
Classifications
1
FEI Numbers
1
Registration Numbers
1
Basic Information
- Device Name
- Kit, Rna Detection, Human Papillomavirus
- Trade Name
- Aptima HPV 16 18/45 Genotype Assay
- PMA Number
- P120007
- Supplement Number
- S024
- Device Class
- FDA Class 3
- Product Code
- OYB
- Generic Name
- Kit, rna detection, human papillomavirus
- Medical Specialty
- Unknown
- Advisory Committee
- Microbiology
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- September 16, 2019
- Date Received
- August 21, 2019
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Increase the manufacturing scale for critical assay components.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| OYB | Kit, Rna Detection, Human Papillomavirus | FDA class 3 | Unknown |